These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28375009)

  • 41. Current computational approaches in medicinal chemistry.
    Khedkar SA
    Curr Top Med Chem; 2010; 10(1):1-2. PubMed ID: 20374194
    [No Abstract]   [Full Text] [Related]  

  • 42. The Impact of Assay Design on Medicinal Chemistry: Case Studies.
    Born JR; Chenniappan VK; Davis DP; Dahlin JL; Marugan JJ; Patnaik S
    SLAS Discov; 2021 Dec; 26(10):1243-1255. PubMed ID: 34225522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpine drug discovery summit: 10th Swiss Course on Medicinal Chemistry.
    Müller G; Ernst B
    ChemMedChem; 2012 Dec; 7(12):2237-40. PubMed ID: 23180615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
    Brown DG; Boström J
    J Med Chem; 2016 May; 59(10):4443-58. PubMed ID: 26571338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calculation and application of activity discriminants in lead optimization.
    Luo X; Krumrine JR; Shenvi AB; Pierson ME; Bernstein PR
    J Mol Graph Model; 2010 Nov; 29(3):372-81. PubMed ID: 20800520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
    Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
    Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose Number as a Tool to Guide Lead Optimization for Orally Bioavailable Compounds in Drug Discovery.
    Wuelfing WP; El Marrouni A; Lipert MP; Daublain P; Kesisoglou F; Converso A; Templeton AC
    J Med Chem; 2022 Feb; 65(3):1685-1694. PubMed ID: 35060378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent trends in microwave-assisted synthesis.
    Wilson NS; Roth GP
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):620-9. PubMed ID: 12197320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
    Ghose AK; Viswanadhan VN; Wendoloski JJ
    J Comb Chem; 1999 Jan; 1(1):55-68. PubMed ID: 10746014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Finding the sweet spot: the role of nature and nurture in medicinal chemistry.
    Hann MM; Keserü GM
    Nat Rev Drug Discov; 2012 Apr; 11(5):355-65. PubMed ID: 22543468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virtual screening in drug design and development.
    Sousa SF; Cerqueira NM; Fernandes PA; Ramos MJ
    Comb Chem High Throughput Screen; 2010 Jun; 13(5):442-53. PubMed ID: 20236061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates.
    Roughley SD; Jordan AM
    J Med Chem; 2011 May; 54(10):3451-79. PubMed ID: 21504168
    [No Abstract]   [Full Text] [Related]  

  • 55. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
    Huisman GW; Collier SJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemists: AI Is Here; Unite To Get the Benefits.
    Griffen EJ; Dossetter AG; Leach AG
    J Med Chem; 2020 Aug; 63(16):8695-8704. PubMed ID: 32459965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automated medicinal chemistry.
    Koppitz M; Eis K
    Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-throughput purification platform in support of drug discovery.
    Liu M; Chen K; Christian D; Fatima T; Pissarnitski N; Streckfuss E; Zhang C; Xia L; Borges S; Shi Z; Vachal P; Tata J; Athanasopoulos J
    ACS Comb Sci; 2012 Jan; 14(1):51-9. PubMed ID: 22032344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrocycles: MCR synthesis and applications in drug discovery.
    Abdelraheem EMM; Shaabani S; Dömling A
    Drug Discov Today Technol; 2018 Nov; 29():11-17. PubMed ID: 30471668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.